Aktie B6E SWEDISH ORPHAN BIOVITRUM AB
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Swedish Orphan Biovitrum AB Xetra

Aktien

B6E

SE0000872095

B6E

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Sobi Q2 2024 report: Strong delivery driven by robust portfolio performance
Swedish Orphan Biovitrum AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
Swedish Orphan Biovitrum AB Updates Earnings Guidance for the Year 2024
The Board of Directors of Sobi exercises authorisation for repurchase of shares for the purpose of securing the company's commitments under incentive programmes
Invitation: Sobi's Q2 2024 report
Sweden's Sobi Begins Rolling Application for Gout Treatment in US
Sobi Initiates Rolling Biologics License Application to FDA for SEL-212 for the Potential Treatment of Chronic Refractory Gout
Sobi initiates rolling biologics license application to FDA for SEL-212 for the potential treatment of chronic refractory gout
Sobi Wins EU Approval for Hemophilia A Drug Altuvoct
European Commission Grants Sobi® Marketing Authorisation for Altuvoct? for Treatment of Haemophilia A
Swedish Orphan Biovitrum : European Commission grants Sobi® Marketing Authorisation for ALTUVOCT™ for treatment of haemophilia A
Swedish Orphan Biovitrum : Sobi to present new haemophilia data at ISTH 2024
Swedish Orphan Biovitrum : Sobi to present new data across its haematology portfolio at the 2024 EHA congress
BerGenBio ASA Enter into A Clinical Trial Agreement with the Mays Cancer Center At the University of Texas Health Science Center At San Antonio and Swedish Orphan Biovitrum AB
Sobi to present new myelofibrosis data at the ASCO 2024 Annual Meeting
Sobi North America Gets FDA Fast Track Designation for Rheumatic Disease Complication Treatment
Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation Syndrome
Bulletin from Sobi's Annual General Meeting (AGM)
Swedish Orphan Biovitrum AB Elects Zlatko Rihter as New Board Member
Sobi Finalizes Inaugural SEK3 Billion Bond Issue
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0LA5K Aktie
  4. B6E Aktie
  5. Nachrichten Swedish Orphan Biovitrum AB
  6. Andere Sprachen